AlphaCentric Advisors’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-11,478	Closed	-$287K	–	253
2024 Q3	$287K	Buy	+11,478	New	+$287K	0.21%	111
2023 Q4	–	Sell	-110,000	Closed	-$1.91M	–	266
2023 Q3	$1.91M	Hold	110,000	–	–	1.08%	30
2023 Q2	$1.55M	Buy	110,000 +27,500	+33%	+$387K	0.86%	43
2023 Q1	$888K	Buy	82,500 +37,500	+83%	+$404K	0.61%	59
2022 Q4	$674K	Buy	45,000 +2,000	+5%	+$30K	0.67%	55
2022 Q3	$552K	Buy	+43,000	New	+$552K	0.57%	53
2021 Q3	–	Sell	-32,500	Closed	-$453K	–	211
2021 Q2	$453K	Buy	32,500 +13,500	+71%	+$188K	0.12%	68
2021 Q1	$352K	Buy	19,000 +3,500	+23%	+$64.8K	0.12%	66
2020 Q4	$274K	Buy	15,500 +11,500	+288%	+$203K	0.11%	46
2020 Q3	$61K	Buy	+4,000	New	+$61K	0.03%	93